إعلان
إعلان
HCAT
Health Catalyst, Inc Common Stock
2.50
USDبرعاية
+0.12
+4.83%
٠٧ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
2.50
0.00
0.00%
تقارير أرباح HCAT
النسبة الإيجابية المفاجئة
HCAT تفوق 23 من 26 آخر التقديرات.
88%
التقرير التالي
بيانات التقرير القادم
٢٤ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$75.56M
/$0.09
التغير الضمني من Q3 25 (Revenue/ EPS)
-1.00%
/+50.00%
التغير الضمني من Q4 24 (Revenue/ EPS)
-5.09%
/+125.00%
Health Catalyst, Inc Common Stock earnings per share and revenue
On ١٠ نوفمبر ٢٠٢٥, HCAT reported earnings of 0.06 USD per share (EPS) for Q3 25, missing the estimate of 0.06 USD, resulting in a -0.66% surprise. Revenue reached 76.32 مليون, compared to an expected 77.42 مليون, with a -1.41% difference. The market reacted with a -5.61% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 المحللين forecast an EPS of 0.09 USD, with revenue projected to reach 75.56 مليون USD, implying an زيادة of 50.00% EPS, and نقصان of -1.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were Health Catalyst, Inc Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Health Catalyst, Inc Common Stock reported EPS of $0.06, missing estimates by -0.66%, and revenue of $76.32M, -1.41% below expectations.
How did the market react to Health Catalyst, Inc Common Stock's Q3 2025 earnings?
The stock price moved down -5.61%, changed from $2.85 before the earnings release to $2.69 the day after.
When is Health Catalyst, Inc Common Stock expected to report next?
The next earning report is scheduled for ٢٤ فبراير ٢٠٢٦.
What are the forecasts for Health Catalyst, Inc Common Stock's next earnings report?
Based on 12
المحللين, Health Catalyst, Inc Common Stock is expected to report EPS of $0.09 and revenue of $75.56M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان